AMPE OTC
Ampio Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +3421.2%
1Y: +6681.5%
3Y: -95.4%
5Y: -100.0%
$0.18
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9M
+59.5% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$9M
+59.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$9M
+59.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$16M | -$17M | -$16M | -$9M |
| Depreciation & Amort. | $1M | $1M | $1M | $1M | $122K |
| Stock-Based Comp. | $405K | $1M | $3M | $953K | $159K |
| Change in Working Capital | $1M | -$2M | $3M | -$3M | -$1M |
| Other Non-Cash Items | $80K | $624K | $80K | -$4M | $1M |
| Operating Cash Flow | -$15M | -$15M | -$14M | -$21M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | -$22K | -$63K | -$97K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$22K | -$63K | -$97K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$12M | -$585K | -$2M | -$79K | -$98K |
| Financing Cash Flow | $14K | $26M | $31M | -$111K | $0 |
| Net Change in Cash | -$1M | $11M | $17M | -$21M | -$9M |
| Cash End of Period | $7M | $17M | $34M | $13M | $4M |
| Free Cash Flow | -$15M | -$15M | -$14M | -$21M | -$9M |